Cervical Carcinoma In Situ
NCI Definition: Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003 
There is 1 clinical trial for cervical carcinoma in situ, of which 1 is open and 0 are completed or closed. Of the trial that contains cervical carcinoma in situ as an inclusion criterion, 1 is phase 2 (1 open).
Pembrolizumab is the most common intervention in cervical carcinoma in situ clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.